btlines

INM NewConnect Periodic report · PAP Biznes

Inventionmed SA (INM) · Q2 2026 results

Share price: 0.11 zł · 2026-11-10

Results Q2 2026 vs Q2 2025 · year over year · published 14 Aug 2026 and 14 Aug 2025

Net income turned to a profit from a loss a year earlier. The report's language is unchanged.

Only a basic analysis is available for this company at the moment.

1 · Numbers

Turned profit

Net income vs Q2 2025

Net income 236.0K vs -217.5K

Revenue −53.7%

2 · How the report reads

Unchanged

Language tone vs last period

Report language: typical for a company report — about as upbeat as in Q2 2025.

Weak signal: formal report language, not a call.

3 · What stood out

Inventionmed SA warns that the ongoing armed conflict in Ukraine may cause delays in the implementation of projects.

Read between the lines

No major shifts flagged this period.

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q2 2026. Ring: Q2 2025.

Report language Typical (was typical)

Typical for a company report — about as upbeat as in Q2 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Full figures

PLN · PAP Biznes report (2026-08-14)

Metric Q2 2026 Q2 2025 Change
Revenue 730.0K 1.6M −53.7%
Operating income 0 175.3K −100.0%
Net income 236.0K -217.5K Turned profit
P/E 12-mo loss 12-mo loss —

Topics

Topics are drawn from the full report text, not management commentary.

Most discussed now

  • Write-downs updating the value of receivables are charged to either other operating expenses or to finance costs - depending on the type of…
  • The Issuer continued activities related to creating advanced medical simulators using virtual reality (VR) technology.
  • The Issuer informed about the conclusion of the funding agreement in ESPI report no. 11/2019 dated May 23, 2019.

Faded since Q2 2025

  • Fading Internally generated intangible assets – costs of completed development works
  • Fading National Court Register - when determining the depreciation period and the annual depreciation rate, the period of economic utility is…
  • Fading National Court Register every quarter from brokerage houses where financial instruments are deposited, valuations of these instruments…
  • Dropped The human capital management model currently adopted by the Company assumes primarily cooperation with persons conducting sole…

Latest announcements

Official filings, newest first.

Similar companies

Healthcare · Medical Devices
All Healthcare companies →